Knight Therapeutics Inc. (OTCMKTS:KHTRF – Get Free Report)’s stock price was down 8.5% during mid-day trading on Monday . The company traded as low as $4.32 and last traded at $4.32. Approximately 1,338 shares traded hands during trading, a decline of 61% from the average daily volume of 3,423 shares. The stock had previously closed at $4.7226.
Knight Therapeutics Price Performance
The firm has a 50-day moving average price of $4.40 and a 200 day moving average price of $4.38.
Knight Therapeutics Company Profile
Knight Therapeutics Inc (OTCMKTS:KHTRF) is a specialty pharmaceutical company headquartered in Montreal, Canada, focused on acquiring, in-licensing and commercializing innovative branded products for the Canadian and Latin American markets. The company secures exclusive marketing and distribution rights to medicines across multiple therapeutic areas, including ophthalmology, pain management, hematology and women’s health. Its portfolio features both prescription pharmaceuticals and specialty products that address unmet patient needs through targeted treatments.
Operating primarily in Canada, Mexico and select Latin American countries, Knight has established strategic alliances with global pharmaceutical firms to introduce novel therapies at various stages of development.
Read More
- Five stocks we like better than Knight Therapeutics
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Knight Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
